An in vitro study of lapatinib effect on endometrial cancer cell lines showed that compared to the non-overexpressing cell lines, the IC50 values of endometrial cancer cell lines that overexpressed HER2 (USPC2, USPC1) were significantly lower (0.33 vs. 4.15 μM). The gene discussed is ERBB2; the disease is endometrial cancer.